Shanghai Junshi Biosciences Co., Ltd.
SSE:688180.SS
35.75 (CNY) • At close June 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 2,486.679 | 3,788.193 | 5,996.936 | 3,504.605 | 3,384.998 | 1,214.026 | 2,763.57 | 266.298 | 111.387 | 363.928 | 29.792 |
| Short Term Investments
| 430.508 | 0 | -0 | 341.539 | 0.017 | 0.017 | 5.516 | 147.434 | 373.469 | 0 | 235.436 |
| Cash and Short Term Investments
| 2,917.187 | 3,788.193 | 5,996.936 | 3,504.605 | 3,385.015 | 1,214.043 | 2,769.086 | 413.732 | 484.856 | 363.928 | 265.228 |
| Net Receivables
| 509.817 | 479.723 | 238.186 | 1,300.812 | 663.323 | 163.21 | 0 | 0.22 | 0.514 | 0 | 0 |
| Inventory
| 584.471 | 538.053 | 599.021 | 484.601 | 343.425 | 180.666 | 48.468 | 30.603 | 7.086 | 0 | 0 |
| Other Current Assets
| 272.342 | 765.106 | 370.762 | 541.721 | 306.954 | 353.197 | 92.63 | 66.451 | 53.687 | 136.663 | 8.297 |
| Total Current Assets
| 4,283.817 | 5,571.075 | 7,204.905 | 5,831.739 | 4,698.717 | 1,911.116 | 2,910.184 | 511.006 | 544.908 | 500.591 | 273.525 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 4,620.372 | 3,808.58 | 3,572.018 | 3,421.326 | 2,534.394 | 2,007.386 | 1,013.749 | 429.179 | 171.759 | 113.166 | 46.729 |
| Goodwill
| 0 | 412.548 | 0 | 0 | 0 | 0 | 0 | 1.519 | 1.519 | 0 | 0 |
| Intangible Assets
| 120.504 | 134.417 | 110.492 | 51.83 | 31.019 | 6.291 | 1.455 | 0.266 | 0 | 3.278 | 3.347 |
| Goodwill and Intangible Assets
| 120.504 | 546.965 | 110.492 | 51.83 | 31.019 | 6.291 | 1.455 | 1.785 | 1.519 | 3.278 | 3.347 |
| Long Term Investments
| 795.897 | 0 | 1,402.836 | 1,123.361 | 422.879 | 141.574 | 13.511 | -142.08 | -150.565 | 0 | 0 |
| Tax Assets
| 87.045 | 0 | 228.427 | 88.55 | 26.113 | 20.59 | 1.288 | 0.139 | 0.17 | 0 | 0 |
| Other Non-Current Assets
| 892.453 | 1,457.092 | 57.608 | 533.914 | 297.742 | 335.483 | 317.123 | 419.68 | 581.239 | 11.345 | 9.339 |
| Total Non-Current Assets
| 6,516.271 | 5,812.637 | 5,371.381 | 5,218.981 | 3,312.147 | 2,511.324 | 1,347.126 | 708.703 | 604.122 | 127.79 | 59.415 |
| Total Assets
| 10,800.088 | 11,342.867 | 12,576.286 | 11,050.72 | 8,010.864 | 4,422.44 | 4,257.31 | 1,219.709 | 1,149.03 | 628.38 | 332.94 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 208.356 | 125.191 | 281.6 | 196.205 | 90.706 | 74.616 | 40.178 | 16.306 | 7.251 | 11.338 | 0.024 |
| Short Term Debt
| 924.895 | 575.322 | 435.414 | 45.068 | 277.566 | 90.737 | 176.506 | 0 | 0 | 0 | 0 |
| Tax Payables
| 39.73 | 17.981 | 35.187 | 80.94 | 19.62 | 10.409 | 2.126 | 0.704 | 0.203 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 4.115 | 45.797 | 1,091.685 | 0 | 2.126 | 0.646 | 0.566 | 0 | 0 |
| Other Current Liabilities
| 1,361.15 | 1,756.662 | 1,022.053 | 1,694.422 | 1,104.69 | 429.614 | 248.003 | 41.55 | 10.942 | 2.825 | 13.048 |
| Total Current Liabilities
| 2,534.131 | 2,475.156 | 1,774.254 | 2,016.635 | 1,492.582 | 605.376 | 471.065 | 58.56 | 18.962 | 14.163 | 13.072 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 2,005.993 | 1,213.245 | 886.167 | 583.127 | 573.213 | 772.228 | 391.763 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 151.273 | 7.254 | 121.615 | 118.776 | 103.809 | 56.32 | 73.349 | 41.815 | 3.062 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -7.504 | 490 | -1.28 | 744.896 | -28.302 | 0 | 0.391 | 0 | 0 |
| Other Non-Current Liabilities
| 158.434 | 326.601 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 2,315.7 | 1,547.1 | 1,007.782 | 701.903 | 677.022 | 828.548 | 465.112 | 41.815 | 3.453 | 0 | 0 |
| Total Liabilities
| 4,849.831 | 4,022.256 | 2,782.036 | 2,718.538 | 2,169.604 | 1,433.924 | 936.177 | 100.375 | 22.415 | 14.163 | 13.072 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 4,151.433 | 3,618.726 | 0 | 1,242.293 | 520.65 | 193.961 | 0 | 0 |
| Common Stock
| 985.69 | 985.69 | 982.872 | 910.757 | 872.496 | 784.147 | 760.31 | 584.75 | 550 | 27.563 | 14.7 |
| Retained Earnings
| -10,323.18 | -9,060.067 | -6,776.635 | -4,388.585 | -3,667.675 | -1,988.895 | -1,242.284 | -519.368 | -198.035 | -66.703 | -31.403 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -142.067 | 105.319 | 237.152 | 48.95 | 49.874 | -0.01 | -1.282 | 4.074 | 0.461 | -0.236 |
| Other Total Stockholders Equity
| 15,216.041 | 15,367.668 | 15,277.702 | 7,050.146 | 4,968.767 | 4,193.267 | 3,797.239 | 535.757 | 771.523 | 645.967 | 332.172 |
| Total Shareholders Equity
| 5,878.551 | 7,151.224 | 9,501.416 | 7,960.903 | 5,841.263 | 2,988.519 | 3,322.246 | 1,120.508 | 1,127.562 | 607.288 | 315.233 |
| Total Equity
| 5,950.257 | 7,320.61 | 9,794.25 | 8,332.182 | 5,841.26 | 2,988.516 | 3,321.133 | 1,119.334 | 1,126.615 | 607.288 | 315.233 |
| Total Liabilities & Shareholders Equity
| 10,800.088 | 11,342.867 | 12,576.286 | 11,050.72 | 8,010.864 | 4,422.44 | 4,257.31 | 1,219.709 | 1,149.03 | 621.45 | 328.306 |